C1QTNF9 and myocardial infarction: To elucidate the effects of CTRP9 in the post‐MI heart in vivo, overexpressing CTRP9 post MI alleviated adverse cardiac dysfunction without improving the 7‐day post‐MI infarct area, rupture rates or survival rates.